Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT

Combining mirtazapine with SSRIs or SNRIs for treatment-resistant depression: the MIR RCT

Background: Depression is usually managed in primary care and antidepressants are often the first-line treatment, but only half of those treated respond to a single antidepressant. Objectives: To investigate whether or not combining mirtazapine with serotonin–noradrenaline reuptake inhibitor (SNRI)...

Full description

Bibliographic Details
Main Authors: David Kessler, Alison Burns, Debbie Tallon, Glyn Lewis, Stephanie MacNeill, Jeff Round, William Hollingworth, Carolyn Chew-Graham, Ian Anderson, John Campbell, Chris Dickens, Una Macleod, Simon Gilbody, Simon Davies, Tim J Peters, Nicola Wiles
Format: Article
Language:English
Published: NIHR Journals Library 2018-11-01
Series:Health Technology Assessment
Online Access:https://doi.org/10.3310/hta22630

Internet

https://doi.org/10.3310/hta22630

Similar Items